Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000895
Filing Date
2024-12-09
Accepted
2024-12-09 17:00:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 11076
  Complete submission text file 0001969223-24-000895.txt   12591
Mailing Address C/O QUIDEL CORPORATION 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Bujarski Robert Joseph (Reporting) CIK: 0001333458 (see all company filings)

Type: 144

Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Subject) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 144 | Act: 33 | File No.: 001-41409 | Film No.: 241535837
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)